文献速递产科母胎医学

预测无症状高危宫颈环扎术女性自发性早产

Predicting spontaneous preterm birth in asymptomatic high-risk women with cervical cerclage.
PubMed 文献 · Ultrasound Obstet Gynecol · 2023-04-17

该研究为前瞻性队列的二次分析,纳入181例无症状高危宫颈环扎术且未用其他预防干预的女性,评估宫颈长度与阴道宫颈定量胎儿纤维连接蛋白(fFN)预测自发性早产。宫颈长度和fFN预测30周前早产AUC分别为0.86和0.84,宫颈长度在病史指征环扎组预测优于超声指征组。

要点

  • 宫颈长度与定量fFN对环扎术后30周前自发性早产有良好预测价值。
  • 宫颈长度预测30周前早产:病史指征组AUC 0.96 vs 超声指征组0.79(P=0.01)。
  • 经腹环扎组无34周前自发性分娩,该组分娩显著延迟(P<0.01)。

核心结论

  • 宫颈长度和定量fFN对宫颈环扎术女性自发性早产保留临床预测效用,病史指征环扎者预测最佳。
  • 这些检测可用于区分风险,并在规划治疗失败相关临床管理时具有效用。

研究设计与样本

  • 前瞻性队列的二次分析,纳入181例无症状高危宫颈环扎术且未接受其他预防干预(包括孕酮)的女性。
  • 受试者于2010年10月至2016年9月在伦敦市中心教学医院早产门诊就诊,接受经腹环扎、病史指征环扎(14周前)或超声指征环扎(宫颈短于25 mm,24周前)。
  • 所有女性在孕中期(16-28周)经阴道超声连续评估宫颈长度,并从18周起进行定量fFN检测。
  • 采用受试者工作特征(ROC)曲线分析评估预测30周前(环扎失败)、34周前和37周前自发性早产的性能。

主要发现

  • 宫颈长度和fFN预测环扎术后30周前自发性早产AUC分别为0.86(95%CI 0.79-0.94)和0.84(95%CI 0.75-0.92)。
  • 宫颈长度预测30周前早产:病史指征环扎组AUC 0.96(95%CI 0.91-1.00) vs 超声指征环扎组0.79(95%CI 0.66-0.91),P=0.01。
  • 定量fFN预测30周前早产:病史指征环扎组AUC 0.91(95%CI 0.75-1.00),超声指征环扎组AUC 0.76(95%CI 0.64-0.89)。
  • 经腹环扎组无34周前自发性分娩,故未计算AUC;该组分娩显著延迟(P<0.01)。

临床怎么用

  • 作者指出宫颈长度和定量fFN可用于区分风险,并在规划治疗失败相关临床管理时具有效用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the performance of the predictive markers of spontaneous preterm birth, cervicovaginal quantitative fetal fibronectin (fFN) and cervical length, in asymptomatic high-risk women with transabdominal, history-indicated or ultrasound-indicated cervical cerclage. METHODS: This was a secondary analysis of a prospective cohort of asymptomatic high-risk women with cervical cerclage and no other prophylactic intervention (including progesterone), who attended the preterm birth clinic at a central London teaching hospital between October 2010 and September 2016. Women had either transabdominal cerclage, placed prior to conception, history-indicated cerclage, placed before 14 weeks' gestation, or ultrasound-indicated cerclage for a short cervix (< 25 mm), placed before 24 weeks. All women underwent serial cervical length assessment on transvaginal ultrasound in the second trimester (16-28 weeks), and quantitative fFN testing from 18 weeks onward. Test performance was analyzed for the prediction of spontaneous preterm birth before 30 weeks (cerclage failure), 34 weeks and 37 weeks, using receiver-operating-characteristics (ROC)-curve analysis. RESULTS: Overall, 181 women were included in the analysis. Cervical length and fFN were strong predictors of spontaneous preterm birth before 30 weeks in women with cerclage, with areas under the ROC curve (AUC) of 0.86 (95% CI, 0.79-0.94) and 0.84 (95% CI, 0.75-0.92), respectively. Cervical length was a better predictor of preterm birth before 30 weeks in women with history-indicated compared to those with ultrasound-indicated cerclage, although both showed clinical utility (AUC, 0.96 (95% CI, 0.91-1.00) vs 0.79 (95% CI, 0.66-0.91); P = 0.01). Quantitative fFN was a strong predictor of spontaneous preterm birth before 30 weeks in women with history-indicated cerclage (AUC, 0.91 (95% CI, 0.75-1.00)) and retained clinical utility in those with ultrasound-indicated cerclage (AUC, 0.76 (95% CI, 0.64-0.89)). There were no spontaneous deliveries before 34 weeks in women with a transabdominal cerclage, so AUC was not calculated. Delivery was delayed significantly in this group (P < 0.01). CONCLUSIONS: Cervical length and quantitative fFN retain clinical utility for the prediction of spontaneous preterm birth in women with cervical cerclage, and prediction is best in women with a history-indicated stitch. These tests can be relied upon to discriminate risk and have utility when planning clinical management with regard to treatment failure. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Ridout AE, Ross G, Seed PT, et al. Predicting spontaneous preterm birth in asymptomatic high-risk women with cervical cerclage. Ultrasound Obstet Gynecol. 2023. PMID: 36647576. doi:10.1002/uog.26161

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。